NO994626L - Substituerte benzamider - Google Patents

Substituerte benzamider

Info

Publication number
NO994626L
NO994626L NO994626A NO994626A NO994626L NO 994626 L NO994626 L NO 994626L NO 994626 A NO994626 A NO 994626A NO 994626 A NO994626 A NO 994626A NO 994626 L NO994626 L NO 994626L
Authority
NO
Norway
Prior art keywords
substituted benzamides
benzamides
substituted
Prior art date
Application number
NO994626A
Other languages
English (en)
Other versions
NO312671B1 (no
NO994626D0 (no
Inventor
Tieno Germann
Stefanie Frosch
Oswald Zimmer
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO994626D0 publication Critical patent/NO994626D0/no
Publication of NO994626L publication Critical patent/NO994626L/no
Publication of NO312671B1 publication Critical patent/NO312671B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94Oxygen atom, e.g. piperidine N-oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19994626A 1998-09-24 1999-09-23 Substituerte benzamider, farmasöytiske preparater inneholdende disse samt anvendelsen av disse for fremstilling avlegemidler NO312671B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843793A DE19843793C2 (de) 1998-09-24 1998-09-24 Substituierte Benzamide

Publications (3)

Publication Number Publication Date
NO994626D0 NO994626D0 (no) 1999-09-23
NO994626L true NO994626L (no) 2000-03-27
NO312671B1 NO312671B1 (no) 2002-06-17

Family

ID=7882078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994626A NO312671B1 (no) 1998-09-24 1999-09-23 Substituerte benzamider, farmasöytiske preparater inneholdende disse samt anvendelsen av disse for fremstilling avlegemidler

Country Status (27)

Country Link
US (1) US6080742A (no)
EP (1) EP0989121B1 (no)
JP (1) JP2000095761A (no)
KR (1) KR20000023339A (no)
CN (1) CN1126741C (no)
AR (1) AR021814A1 (no)
AT (1) ATE309987T1 (no)
AU (1) AU750919B2 (no)
BR (1) BR9906070A (no)
CA (1) CA2283021A1 (no)
CO (1) CO5160263A1 (no)
CZ (1) CZ295496B6 (no)
DE (2) DE19843793C2 (no)
DK (1) DK0989121T3 (no)
ES (1) ES2251143T3 (no)
HK (1) HK1026211A1 (no)
HU (1) HUP9903216A3 (no)
IL (1) IL132012A (no)
NO (1) NO312671B1 (no)
NZ (1) NZ337531A (no)
PE (1) PE20001050A1 (no)
PL (1) PL194897B1 (no)
RU (1) RU2221783C2 (no)
SI (1) SI0989121T1 (no)
SK (1) SK283316B6 (no)
UY (1) UY25712A1 (no)
ZA (1) ZA996133B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
WO2001070688A2 (de) * 2000-03-20 2001-09-27 Grünenthal GmbH N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
US7431920B2 (en) * 2000-07-19 2008-10-07 Pepgen Corporation Method of treating IL-10 deficiency
US20050118138A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US20050201981A1 (en) * 2004-03-10 2005-09-15 Chih-Ping Liu Method of optimizing treatment with interferon-tau
US20050084478A1 (en) * 2000-10-17 2005-04-21 Chih-Ping Liu Combination therapy using interferon-tau
US20040247565A1 (en) * 2000-07-19 2004-12-09 Chih-Ping Liu Method of treatment using interferon-tau
US20050118137A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
ES2338534T3 (es) * 2001-02-27 2010-05-10 The Governement Of The Usa, Represented By The Secretary Department Of Health And Human Services Analogos de talidomina como inhibidores de la angiogenesis.
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
DE10163595A1 (de) * 2001-12-21 2003-08-07 Gruenenthal Gmbh In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CN1867331B (zh) 2003-09-17 2010-05-26 美国政府健康及人类服务部 作为TNF-α调节剂的沙利度胺类似物
US20060078942A1 (en) * 2004-03-10 2006-04-13 Pepgen Corporation Method of treatment using interferon-tau
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
AU2007238785B2 (en) * 2006-04-13 2013-02-07 Agnieszka Ambrozak Tetrahalogenated compounds useful as inhibitors of angiogenesis
US8314107B2 (en) 2008-04-23 2012-11-20 Rigel Pharmaceuticals, Inc. Carboxamide compounds and methods for using the same
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
KR102316961B1 (ko) * 2020-01-29 2021-10-26 프라비바이오 주식회사 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545672B2 (de) * 1965-05-08 1974-11-07 Chemie Gruenenthal Gmbh, 5190 Stolberg Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ZA996133B (en) 2000-04-06
AU750919B2 (en) 2002-08-01
DE59912795D1 (de) 2005-12-22
NO312671B1 (no) 2002-06-17
CZ338699A3 (cs) 2000-08-16
DK0989121T3 (da) 2005-12-12
CA2283021A1 (en) 2000-03-24
ES2251143T3 (es) 2006-04-16
PL194897B1 (pl) 2007-07-31
HK1026211A1 (en) 2000-12-08
IL132012A (en) 2004-02-19
AR021814A1 (es) 2002-08-07
PE20001050A1 (es) 2000-11-18
UY25712A1 (es) 2001-05-31
KR20000023339A (ko) 2000-04-25
NO994626D0 (no) 1999-09-23
JP2000095761A (ja) 2000-04-04
RU2221783C2 (ru) 2004-01-20
CO5160263A1 (es) 2002-05-30
BR9906070A (pt) 2000-08-15
DE19843793C2 (de) 2000-08-03
CN1250048A (zh) 2000-04-12
IL132012A0 (en) 2001-03-19
DE19843793A1 (de) 2000-04-20
US6080742A (en) 2000-06-27
SI0989121T1 (sl) 2006-04-30
SK130899A3 (en) 2000-06-12
SK283316B6 (sk) 2003-05-02
HUP9903216A3 (en) 2000-10-30
EP0989121B1 (de) 2005-11-16
EP0989121A1 (de) 2000-03-29
PL335555A1 (en) 2000-03-27
CZ295496B6 (cs) 2005-08-17
HUP9903216A2 (hu) 2000-06-28
ATE309987T1 (de) 2005-12-15
AU4886199A (en) 2000-03-30
CN1126741C (zh) 2003-11-05
NZ337531A (en) 2000-09-29
HU9903216D0 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
DE59901560D1 (de) Retrograder tibianagel
DE59902874D1 (de) Buchsenkontakt
NO994626L (no) Substituerte benzamider
DE59907306D1 (de) Fadenchangierung
ID23287A (id) Trisiklik tersubstitusi
DE59906931D1 (de) Exzenterzahnradgetriebe
NO993442L (no) Tauheis
DE59903966D1 (de) Exzenterzahnradgetriebe
ATE262513T1 (de) Benzoylpyridazine
ID23219A (id) Trisiklik tersubstitusi
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DK0969233T3 (da) Strömningsbegrænser
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
DE19842103B4 (de) Stanznietzuführung
DE59808995D1 (de) Endomikroskopsystem
DE59902088D1 (de) Achrathermer Reimager
DE59903616D1 (de) Rollenwicklerwalze
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59912532D1 (de) Substituierte acylaminophenyl-uracile

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees